Breast and Cervical Cancer

About Conference

ME Conferences organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology. Oncological events are held every year across UK, Europe, Asia, Middle East, Australia and USA that support oncology conferences from 1000 more scientific societies and Publishes 500 open access journals which contain over 30000 eminent personalities, apparent scientists as editorial board members. BreCeCan 2018 comes under Breast and cervical cancer conferences.

With the best expertise members of organizing committee, we are gathered to be outline the program for the 4^th World Conference on Breast and Cervical Cancer, October 21-22, 2019 in Helsinki, Finland. This conference leads to spread profound knowledge of breast and cervical cancer. This congregation will strengthen the ideas about cancer-related preventions and problems.

Breast Cancer is the utmost common cancer among women in the United States, aside from non-melanoma skin cancer. In addition, breast cancer is one of the primary causes of cancer death among women of all races and Hispanic ethnicity. Cervix is the lower portion of the uterus which opens into the vagina. When the peculiar cells of the cervix grow out of functioning, cervical cancer takes place. Cervical cancer can be without problems detected within the early tiers by a look at referred to as ‘Pap check’.

Why Attend?

It will offer promotional approximately the special records of Breast and Cervical Most Cancers. It will also offer an awareness of the radical inventions and techniques. It is very beneficial for the scholars, physicians, nurses, doctors, fitness care humans, Professors because it offers knowledge on the subject. It furthermore gives opportunities to the Breast and Cervical Most Cancers Societies worldwide to show off their know-how and have head to head assemblies with researchers growing their enterprise prospects. It furthermore gives an opportunity to know their marketplace Participants.

Who attends?

• Physicians
• Researchers
• Hematologists
• Gynecologists
• Dermatologists
• Surgical Oncologists
• General Oncologists
• Pharmacy industries
• Students dealing oncology projects
• Women’s Healthcare professors, Nurses
• Professors and Asst. Professors in Oncology
• Directors/Co-directors & Medical Oncologists
• Radiation Oncologists, Surgeons, Gynecologists
• Diagnostic laboratory professionals and industry professionals

The Future is Today, Come and be a Part of it..!!

Conference Highlights:

• Breast Cancer Biology 
• Cervical Cancer Biology
• Cancer Genomics
• Immunological Approaches to Cancer Therapy
• Breast and Cervical Cancer Screening
• Male Breast Cancer
• Breast Reconstruction (Oncoplastic Surgery)
• Breastfeeding and Breast Cancer
• Chemotherapy and Cancer
• Molecular Oncology in Breast Cancer
• Cancer Epigenomics: Beyond Genomics
• HPV and Pregnancy
• Nanotechnology / Nanomedicines in Cancer Treatment
• Cancer Vaccination
• Women’s Health and Contraception
• Cancer Therapeutics
• Gynecologic Oncology
• Complementary and Alternative Medicine for cancer
• Cancer Biomarkers

Sessions/ Tracks

Track 1: Breast Cancer Biology

Breast cancer starts when cells in the breast begin to grow abnormally. These cells frequently form a tumor that can often be seen on an x-ray or felt a lump. Breast Cancer occurs mostly in women, but very rare chances to get in men. This starts from different parts of the breast. Most breast cancers begin in the duck carry milk to the nipple. Many of the breast cancer form lumps, but not all do. Most of the lumps are begin and not cancer (malignant). Non-cancerous breast tumors are irregular developments, but they do not spread outside of the breast and they are not life-threatening. Investigating the difficulties regarding brilliance in Breast Cancer Conferences, Oncology Meetings research and investigation which incorporates provoke keynote introductions, Oral talks, Poster introductions, and Exhibitions.

Track 2: Cervical Cancer Biology

The Cervix is the lower some portion of the uterus which opens into the vagina. At the point when the strange cells of the cervix become crazy, cervical disease happens. Cervical growth can be effectively known in the beginning of periods by a test called 'Pap test'. Most sorts of cervical disease are caused by an infection known as Human Papillomavirus or HPV. There are many kinds of HPV. However, every kind does not bring about cervical tumor. A few causes genital warts which do not have any side effects. The main approaches of cervical growth are smoking, use of oral preventative pills and getting numerous pregnancies. The side effects of cervical malignancy incorporate unpredictable seeping from the vagina other than the conclusive time traverse of general menstrual cycle, torment in the lower stomach area, torment amid sexual relations and irregular vaginal release. Each sort of cervical malignancy isn't lethal to the ladies. Treatment that incorporates surgeries and chemotherapies has been turned out to be fruitful in treating cervical malignancy in the underlying stages.

Track 3: Cancer Genomics

Genes are instructions which tell the body how to make all the proteins it needs to continue and produce. Cancer genomics is the study of the whole DNA arrangement and quality articulation contrasts between tumour cells and typical host cells. It expects to comprehend the genetic premise of tumour cell growth and the development of the growth genome under change and determination by the body condition, the immune system and therapeutic interventions.

In cancer cells, little variations in the genetic letters can change what a genomic word or sentence implies. A transformed letter can make the cell make a protein that doesn't enable the cell to fill in as it should. These proteins can influence cells to develop rapidly and make harm neighbouring cells. By concentrate the growth genome, researchers can find what letter changes are making a cell turn into a disease. The genome of a tumour cell can likewise be utilized to disclose to one kind of disease from another. Now and again, examining the genome in a growth can help recognize a subtype of malignancy inside that write, for example, HER2+ breast tumour. Understanding the tumour genome may likewise enable a specialist to choose the best treatment for every patient.

Track 4: Immunological Approaches to Cancer Therapy

Cancer immunotherapy (also called immuno-oncology) is the application of the safe outline to regard cancer. Immunotherapies can be divided as dynamic, inactive or mixture (dynamic and detached). These procedures abuse the way that growing cells regularly have elements on their surface that can be distinguished by the safe framework, known as tumor-associated antigens (TAAs); they are frequently proteins or different macromolecules (e.g. starches). Dynamic immunotherapy guides the safe agenda to attack tumor cells by focusing on TAAs. Uninvolved immunotherapies improve existing hostile to tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes, and cytokines.

The immune-system efficiently prevents cancer, though life-threatening immune-depression expands its rate. Malignancy immune-prevention is a technique in view of the idea that advancement of tumor insusceptibility in sound people reduces growth to chance. It can be seen as a sort of chemoprevention. For growth immune-prevention, the malignancy universe can be conveniently separated between tumors caused - specifically or in a roundabout way - by irresistible operators and every other tumor. Immuno-prevention of tumors produced by appealing operators is as of now implemented at the populace level for hepatitis B infection (HBV); related hepatocellular carcinoma and for tumors caused by human papillomaviruses (HPV), like cervical carcinoma. Now the test is to create immunological measures to retain the mass (>80%) of human tumor load, irrelevant to diseases.

Track 5: Breast and Cervical Cancer Screening

Cancer among women is a noteworthy general medical issue in the United States. Around 40% of American ladies are determined to have a no dermatological development among their period, and breast tumor is second just to lung disease as a cause for malignancy-related mortality amongst women. The cervical disease is the tenth most regular tumor among ladies and records for right around 2% of female malignancy passing. The American Cancer Society expects that about 40200 women will have kicked the bucket from breast growth and 4400 will have passed on from the cervical illness in the year 2001.

Mammography and Papanicolaou (Pap) tests are important parts of early detection and treatment, and death rates are significantly reduced when breast and cervical tumors are identified and treated at a beginning time.

Track 6: Male Breast Cancer

Breast cancer in men could be a rare illness. but about 1% of whole breast cancers arise in men. Men, and women, girls and boys altogether have breast tissues. the varied hormones in girls' and women's bodies stimulate the breast tissue to grow into full breasts. Boys' and men's bodies commonly do not build a lot of the breast-stimulating hormones. As a result, their breast tissue typically stays flat and small. however generally men will develop real breast secretory organ tissue as a result of they take bound medicines or have abnormal secretion levels. Breast and Cervical Malignancy Congress incorporates the exchange on future elements of male and feminine breast illness. In 2017, about 2,470 men are expected to be diagnosed with the illness. For men, the period risk of being diagnosed with carcinoma is regarding 1 in 1000.

Track 7: Breast Reconstruction (Oncoplastic Surgery)

Breast-conservation surgery (BCS) is set up as a comfortable alternate for most ladies with early breast illness. As of late, propels in Oncoplastic procedures have diminished surgical injury and along these lines are equipped for protecting the breast shape and personal fulfilment. Notwithstanding the most BCS abnormalities can be made do with the essential conclusion, the stylish result might be unaware. Oncoplastic reproduction may start at the season of BCS (quick), weeks (deferred prompt) or months to years subsequently (postponed). With quick remaking, the surgical procedure is smooth, since the two approaches can be related to one agent setting. Furthermore, it licenses more wide extraction of the tumor, with a major mean volume of the example and possibly reducing the rate of edge association. The Oncoplastic strategies are known with volume subtraction or substitution methods with closer folds, latissimus dorsi myocutaneous fold, and degeneration mammoplasty/mastopexy. Breast and Cervical Cancer Conferences is an unmistakable stage to unite worldwide predictable scholastics in the field of tumor treatments. Maximum breast reconstructions achieved today are immediate reconstructions with implants.

Track 8: Breastfeeding and Breast Cancer

Breastfeeding is a complex yet important responsibility for some mothers since it might be painful for the reliability of both baby and mother. Studies determine that even irrelevant breastfeeding reduces a lady's danger of breast cancer by around 30 percent. This has even seemed in ladies with a BRCA1 mutation, which builds the risk for breast growth. On the off chance that a patient is determined to have breast cancer while nursing, most doctors will advise that they quit breastfeeding. Frequent treatments utilized among breast malignancy treatment might be passed to the infant through breast milk, with chemotherapies, hormone treatments and anaesthesia managed amid surgery. Stopping breastfeeding will similarly reduce blood flow to the breasts, making them smaller, less difficult to look at and more averse to wind up simply contaminated.

Track 9: Chemotherapy and Cancer

Chemotherapy is a cancer treatment that makes use of tablets to stop the boom of most cancers’ cells, both by way of killing the cells or through preventing them from dividing. When chemotherapy is taken by orally or vaccinated into a vein or muscle, the drug enters the bloodstream and may spread most cancers cells in the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body deep space with the abdomen, the drugs affect most cancers cells in those areas (nearby chemotherapy). Breast and Cervical Cancer Conference has given superb breast and cervical growth screening measures and varied technique of medications. The manner the chemotherapy is given depends on the type and degree of the most cancers being handled. Systemic chemotherapy is used in the medicine of breast utmost cancers.

Track 10: Molecular Oncology in Breast Cancer

In the present period, sub-atomic oncology has cleared its way in the exhaustive cancer care and is assuming a critical part, particularly in the disclosure of novel cell, focuses to misuse for novel focused on medications, new biomarkers distinguishing proof for early malignancy location, and to give a superior characterization of tumors for guess and treatment choice. The sub-atomic premise of breast carcinogenesis including hereditary and epigenetic occasions that outcome in the changed articulation of various qualities is yet not completely comprehended and still should be deciphered more, which mirrors the unpredictability of the sub-atomic modifications that portray tumor cells.

The majority of the breast malignancy genome is specifically subdued; around, 3-5% of qualities are dynamic in a specific tumor cell that is administered by the direction of quality articulation, for the most part at the level of translation. Cell bother (change) causes changes in quality articulation that outcome in the declaration of many quality items and the concealment of others. Consequently, sub-atomic heterogeneity is created that describes a tumor of various histology and adds to the changeability in result and reaction to treatment. Further, huge changeability additionally exists for tumors of a particular histologic write. Till as of late, in breast disease administration, clinical choices, visualizations, and expectations were constructed exclusively upon histopathologic investigation, or one or little quantities of qualities or their appearances (proteins) in the tumor tissue, yet this approach has been deficient and neglected to create exact conclusions. There has been a rise of the new worldview called "Genomic Paradigm," a move from the seniority "Clinico-Pathological Paradigm"

Track 11: ​Cancer Epigenomics: Beyond Genomics

Cancer epigenetics is the investigation of epigenetic alterations to the genome of tumor cells that don't include an adjustment in the nucleotide succession. Epigenetic adjustments are as critical as hereditary transformations behind the progress of a cell from ordinary to malignant, and their control holds awesome guarantee for disease counteractive action, discovery, and treatment. In various kinds of growth, an assortment of epigenetic systems can be irritated, for example, hushing of tumor silencer qualities and initiation of oncogenes by adjusted CpG island methylation designs, histone changes and dysregulation of DNA restricting protein.

DNA methylation changes in disease cells incorporate the loss of methylation at regularly methylated arrangements (hypo-methylation) and the pickup of methylated successions at locales normally un-methylated (hypermethylation). Growth Epigenomics includes the investigation of epigenetic changes in malignancy and can be confused by inquiries of circumstances and end results.

Track 12: HPV and Pregnancy

HPV is probably not going to influence pregnancy or child's wellbeing. On the off chance that you have genital warts, they may become quicker amid pregnancy, conceivably from the additional vaginal release that gives the infection a clammy developing condition, hormonal changes, or changes in your immune system. Much of the time, warts won't represent any issues for the patient or her infant. It's workable for you to pass the infection to your child, yet this doesn't occur all the time. Regardless of whether your youngster contracts HPV, he's probably going to defeat it all alone with no side effects or issues. In the far-fetched occasion that your youngster gets the kind of HPV that causes genital warts, he may create warts on his vocal strings and different territories at some point in outset or adolescence. This condition, called repetitive papillomatosis, is intense, yet luckily it's additionally uncommon.

Track 13: Nanotechnology / Nanomedicines in Cancer Treatment

The use of nanotechnology in growth treatment offers some energizing potential outcomes, including the likelihood of obliterating malignancy tumors with negligible harm to sound tissue and organs, and additionally the discovery and disposal of diseased cells before they frame tumors. One treatment being worked on includes focused on chemotherapy that conveys a tumor-executing specialist called tumor rot factor alpha (TNF) to grow tumors. TNF is connected to a gold nanoparticle alongside Thiol-derivatized polyethylene glycol (PEG-THIOL), which conceals the TNF bearing nanoparticle from the invulnerable framework. This permits the nanoparticle to course through the circulatory system without being assaulted.

Track 14: Cancer Vaccination

Certain sorts of chemotherapy and radiation treatment can debilitate the invulnerable framework, putting malignancy patients at expanded hazard forever undermining diseases. Along these lines, numerous tumor patients may need to get revaccinated against ailments they got immunizations for as youngsters. Antibodies require a sound insusceptible framework that is ready to perceive and execute illness-causing germs. Furthermore, it takes a sound insusceptible framework no less than 2 weeks from the season of immunization to begin perceiving and eliminating germs. That implies inoculation timing is similarly as essential as getting the immunization itself. When all is said in done, immunizations aren’t prescribed amid chemotherapy or radiation treatment.

Track 15: Women’s Health and Contraception

Enhancements in the finding and administration of disease have expanded personal satisfaction for patients with malignancy both amid and after treatment. Numerous malignancy patients are seeing someone where sexual movement is a piece of their lives. Unprotected intercourse can bring about pregnancy notwithstanding when the possibility of fruitfulness is viewed as negligible. Pregnancy might be undesired as a result of the potential teratogenic impacts of disease medications, or dread that the pregnancy will adversely influence the course of the growth. Breast and Cervical Cancer Conference has given superb breast and cervical growth screening procedures and diverse method of medications. Ladies experiencing malignancy treatment and female tumor survivors will probably end a pregnancy, an activity that has mental and passionate results. Accordingly, it is vital to give fitting advising about contraception to these ladies.

Track 16:  Cancer Therapeutics

The typical treatment modalities are related to serious symptoms and high harmfulness which thusly prompt low personal satisfaction. This audit envelops novel systems for more powerful chemotherapeutic conveyance planning to create better anticipation. Right now, tumor treatment is a profoundly unique field and huge advances are being made in the improvement of novel growth treatment procedures. As opposed to customary malignancy therapeutics, novel methodologies, for example, ligand or receptor-based focusing on, intracellular medication focusing on, quality conveyance, tumor undifferentiated organism treatment, attractive medication focusing on and ultrasound-interceded sedate conveyance, have included new modalities for growth treatment. 

Track 17: Gynecologic Oncology

Gynecologic Oncology is a field of drug that spotlights on malignancies of the female conceptive framework, including ovarian disease, uterine cancer, vaginal tumor, cervical disease, and Vulvar malignancy. In Oncology Meeting 2019, speakers will talk about the key focuses with respect to immunotherapy, Immune checkpoint inhibitors to treat disease, and related investigations of tumor inoculation. As authorities, they have broad preparing in the determination and treatment of these tumors.

Track 18: Complementary and Alternative Medicine for cancer

The natural solution utilizes plants, or a blend of plant separates, to treat disease and advance well-being. The two most normal composes utilized as a part of the UK are Western and Chinese home-grown pharmaceutical. Home-grown drug intends to re-establish your body's capacity to secure, direct and recuperate itself. It is an entire body approach that takes a gander at your physical, mental and enthusiastic prosperity. It is at times called Phyto-medicine, Phyto-therapy or organic solution. Numerous cutting edge drugs are produced using plants. However, botanists don't separate plant substances in the way the medication business does. In Breast and Cervical, Malignancy gatherings will likewise talk about various approaches to avoid growth and related infections. The two most normal sorts of natural medication utilized as a part of the UK are Western and Chinese home-grown pharmaceutical. Less basic composes incorporate Tibetan or Ayurveda medication (Indian).

Track 19: Cancer Biomarkers

Biomarkers are particles that show typical or strange process occurring in your body and might be an indication of a hidden condition or ailment. Different kinds of the molecule, for example, DNA (genes), proteins or hormones, can serve as biomarkers since they all demonstrate something about your Health. Biomarkers might be created by the cancer tissue itself or by different cells in the body in the response to cancer. They can be found in the blood, stool, pee, tumor tissue, or different tissues or organic liquids. Notably, biomarkers are not limited to cancer. There are biomarkers for heart disease, multiple sclerosis, and many other sicknesses.

A Cancer biomarker defines as a substance or process that is demonstrating the presence of cancer in the body. A biomarker might be a molecule emitted by a tumor or a particular reaction of the body to the presence of cancer. Hereditary, epigenetic, proteomic, glycomic and imaging biomarkers can be utilized for cancer diagnosis, visualization, detection, and the study of disease transmission. Ideally, such biomarkers can be measured in non-invasively collected bio-fluids like blood or serum.

Market Analysis

BreCeCan 2019 invites participants, moderators, and exhibitors from everywhere throughout the world to Helsinki, Finland. We are charmed to welcome all of you to go to and enlist for the '' 4^th World Conference on Breast and Cervical Cancer '' which will be held on October 21-22, 2019 in Helsinki, Finland. The sorting out the advisory group is preparing for an energizing and instructive gathering program including entire addresses, symposia, workshops on an assortment of subjects, notice introductions, and different projects for members from everywhere throughout the world. We welcome you to go along with us at the BreCeCan-2019, where you will make certain to have an important involvement with researchers from around the globe. All individuals from the Breast and Cervical Cancer-2018 arranging board anticipate meeting you in Helsinki, Finland. 

IMPORTANCE AND SCOPE:

BreCeCan 2019 offers with Breast most cancers expertise and traits, Screening, Detecting and Diagnosing Breast most cancers, Breast most cancers therapy, prevention and medicinal drug, surgical operation choices for Breast most cancers, Personalized remedy, medical trials of Breast most cancers, Male Breast cancer, Cancer Biomarkers, and Breast Cancer Nursing. Breast most cancers are the main kind of cancer from which most of the ladies are struggling internationally. Cognizance approximately the breast most cancers dangers, signs and symptoms and treatment could be very critical. The advent of the latest strategies within the area of drugs in addition to prognosis is going on worldwide. Breast cancer convention 2019 offers a platform for sharing of facts approximately the breast most cancers remedy techniques and newly advanced strategies for the same as nicely as offer platform approximately the latest researches on breast most cancers.

This occasion includes activating keynote presentations, oral talks, poster presentations, and exhibitions. In line with the World Health Organization (WHO) in 2012, round 521,000 people died due to breast most cancers and this variety is predicted to growth within the near destiny. Like different metastatic cancers, surgical elimination of metastatic breast cancer is deemed useless and regularly effects in elevated threat of loss of life (80% - 90% of the recognized population). Prognosis is generally based at the stage of breast most cancers within the patient; this staging is carried out by using the same old TNM staging technique, wherein T stands for tumor, N stands for node swelling, accompanied through TNM i.e. the metastatic stage of the most cancers. Those manifestations are utilized inside the class of metastatic breast most diseases into 4 levels, levels 1-three involves the moderate spread of carcinoma from various areas of the breast. But doesn’t contain metastasis; degree 4 shows a full-blown metastasis which indicates an involvement of lymph nodes near or remote from the breasts and spread to different organs consisting of bones, lung and the mind.

Cervical cancer is the second maximum usually conventional cancer and the 1/3 greatest cause of loss of life in girls, with 530,000 new instances discovered each 12 months the global cervical most cancers diagnostics exams marketplace is segmented through taking a look at kinds into Pap smear exams, colposcopy, HPV checking out, Endo-Cervical Curettage (ECC) procedure and others, which incorporates cone biopsy and loop electrosurgical excision procedure (LEEP). The Pap smear exams section is also predicted to develop at a CAGR of extra than 6% throughout the forecast period from 2014 to 2020 North America become the largest marketplace for cervical cancer diagnostic tests in 2013. The global cervical cancer diagnostic checks market has been segmented into 4 principals nearby markets: North America, Europe, Asia Pacific and relaxation of global. The marketplace length estimations and forecasts for the length 2012 to 2020 were furnished for each of those areas at a phase stage, in terms of USD million at the side of the CAGR for the forecast period 2014 to 2020. Factors which have pushed the market in North the USA are growing prevalence of cervical most cancers cases, fast technological improvements, and developing attention approximately malignant consequences of cervical most cancers among people. Further, diverse reimbursement rules associated with the remedy of cervical most cancers could most possibly gas the increase of the market within the next few years. However, Asia Pacific is projected to witness the highest boom fee over the forecast period from 2014 to 2020.

Figure 1: Breast Cancer: Estimated age-standardized rates worldwide according to Age groups.

Figure 2: Cervical Cancer: Estimated age-standardized rates worldwide according to Age groups.

• Estimated number of new cases of breast cancer diagnosed in 2017:

           17,730 =    144 males +    17,586 females

• Estimated % of all new cancer cases diagnosed in 2017 = 13%
• Estimated number of deaths from breast cancer in 2017:

           3,114 =    28 males +     3,087 females

• Estimated % of all deaths from cancer in 2017 = 6.5%
• Chance of surviving at least 5 years (2009–2013) = 90%

WHY FINLAND?

The Finnish working condition is steady and unsurprising. Finland is a member of the European Union. Finland is the main Nordic nation with Euro and has a low corporate tax rate, only 20 %. Therefore, many foreign companies have established operations in Finland for the long-term and enjoy a high return on investment. With access to top high tech talent and a Silicon Valley-inspired business culture, Finland is an R&D hotspot and a testing ground for companies looking for business transformation.

Finland is well known for its many lakes, almost 200,000 of them. Tampere is the greatest city on the Finnish Lakeland with other real urban communities being Jyväskylä, Mikkeli, Lahti, Joensuu, Lappeenranta, Kuopio, and Savonlinna. Finland is likewise known to have magnificent water quality, and green profound woods and timberlands around the ocean, streams, and the conduits. In wintertime, Finland gives chances to cross-country skiing and snow-capped skiing. A significant number of the prevalent ski resorts are arranged north of the Arctic Circle in Lapland; however, there are exemptions like Kuusamo in the north-eastern piece of Oulu Province and Himos in Jämsä, just 200 km North from Helsinki.

Santa Clause is commonly known to live on Korvatunturi in Finland. In the town of Rovaniemi, there is the Santa Claus Village for vacationers to visit. Moomin World in the edges of Naantali is an amusement stop in light of Tove Jansson tyke books about the Moomin.

RELATED CONFERENCE

• 8^th World Conference on Women’s Health and Breast Cancer, December 17-18, 2018 Abu Dhabi, UAE
   
• 30th Experts Meet On Cancer Therapy, November 14-15, 2018 Melbourne, Australia
   
• 2nd International Conference on Cancer Genetics and Epigenetics, November 12-13, 2018 Tokyo, Japan
   
• 2nd Global Meeting on Clinical Oncology & Radiology, Mar 27-28, 2019 Hong Kong.
   
• 5th International Congress on Epigenetics & Chromatin, August 22-23, 2019 Vienna, Austria.
   
• 26th Cancer Genomics Congress: New Era for Cancer Prevention, October 21-22, 2019 Abu Dhabi, UAE
   
• International Conference on Biomarkers and Cancer Targets, November 18-19, 2019 Dubai, UAE
   
• 27th World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology, December 07-08, 2018 Chicago, Illinois, USA
   
• 13th World Biomarkers Congress, November 29-30, 2018 Dublin, Ireland
   

RELATED SOCIETIES:

EUROPE:

European Society of Oncology Pharmacy; European Society of Surgical Oncology; Organization of European Cancer Institutes; Union for International Cancer Control; Universal Medical Centre; Society of Nuclear Medicine and Molecular Imaging; European Society of Gynaecological Oncology; French Endocrine Society; German Society of ORL HNS; Association, International Association of Endocrine Surgeons; International Federation of Oto-Rhino-Laryngological Societies; International Thyroid Oncology Group; Society of Nuclear Medicine and Molecular Imaging; European Association of Urology; European Society For Medical Oncology; Rational Therapy for Breast Cancer; European Laryngological Society; European Society of Endocrinology; French Endocrine Society; European Society of Skin Cancer Prevention; Society of Nuclear Medicine and Molecular Imaging; European Oncology Nursing Society; European Organization for Research and Treatment of Cancer; Dutch Endocrine Society; Association of European Cancer Leagues; EAU Section of Oncological Urology; European Academy of Cancer Sciences; European Association for Cancer Research, European Association for Neuro-Oncology; European Organization for Research and Treatment of Cancer; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; European Organisation for Treatment of Trophoblastic Disease; European Breast Cancer Coalition EUROPA DONNA; European Cancer Organization; European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer; European School of Oncology; European Society for Medical Oncology; European Society for Therapeutic Radiation and Oncology; European Society of Breast Cancer Specialists; European Society of Gynaecological Oncology; European Society of Oncology Pharmacy; European Society of Breast Cancer Specialists; European Society of Gynaecological Oncology; European Society of Paediatric Oncology; European Society of Skin Cancer Prevention; European Society of Surgical Oncology; Mediterranean Oncology Society; Organization of European Cancer Institutes; European Research Organization on Genital Infection and Neoplasia; European Group for Blood and Marrow Transplantation; European Society of Breast Cancer Specialists; European Network of Cancer Registries; European Cancer Organisation; European Oncology Nursing Society.

USA:

Acoustic Neuroma Association; American Association for Cancer Research; American Bone Marrow Donor Registry; American Brain Tumor Association; American Cancer Society; American Childhood Cancer Organization Society for Immunotherapy of Cancer Radiation Therapy; Oncology Group Prevent Cancer Foundation; Pancreatic Cancer Action Network; Oncology Nursing Society; Onco-fertility Consortium; Ocular Melanoma Foundation; National Lung Cancer Partnership; National Familial Pancreas; Tumor Registry National Familial Lung Cancer Registry; National Council on Skin Cancer Prevention; National CML Society National Children's Leukaemia Foundation; National Cancer Registrars Association; National Brain Tumor Society; Musculoskeletal Tumor Society; Melanoma Research Foundation Lymphoma Research Foundation; Lung Cancer Foundation of America Haematology/Oncology Pharmacy Association; Foundation for Women's Cancer, Society for Neuro-Oncology, Society for Radiation Oncology Administrators; Society of Surgical Oncology, Society of Gynaecologic Oncology; Society of Gynaecologic Nurse Oncologists;  Southwest Oncology Group American Association of Endocrine Surgeons; American Association of Clinical Endocrinologists; American Head and Neck Society; American Thyroid Association; Association of Women Surgeons; Canadian  Association of Pathologists; Canadian Society of Otolaringology – Head and Neck Surgery; Latin American Cancer Society.

ASIA PACIFIC AND MIDDLE EAST

The National Asian Breast Cancer Initiative, Asian Clinical Oncology Society; Childhood Cancer International; World Cancer Research Fund International; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Korean Society for Head and Neck Oncology; Korean Society of Thyroid-Head and Neck Surgery; Korean Society of Otorhinolaryngology-Head and Neck Surgery; The Israel Society of Head and Neck Surgery and Oncology ; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society, Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society; Association of Oncologists of Uzbekistan; Chinese Society of Clinical Oncology (CSCO); Hong Kong Cancer Therapy Society; Indian Society of Medical & Paediatric Oncology (ISMPO); Indonesian Society of Haematology and Medical Oncology (ISHMO); Iranian Cancer Association (ICA); Iranian Society of Clinical Oncology (ISCO); Iranian Society of Medical Oncology and Haematology (ISMOH); Japan Society of Clinical Oncology (JSCO); Japanese Society of Medical Oncology (JSMO); Korean Association for Clinical Oncology (KACO); Malaysian Oncological Society; Medical Oncology Group of Australia (MOGA); Myanmar Oncology Society; New Zealand Society for Oncology (NZSO); Oncology Club, Bangladesh; Pakistan Society of Clinical Oncology (PSCO); Philippine Society of Medical Oncology (PSMO); Singapore Society of Oncology (SSO); Taiwan Oncology Society (TOS); Thai Society of Clinical Oncology (TSCO); Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery; The Japan Endocrine Society; The Japan Thyroid Association; Foundation for Head and Neck Oncology;  Israel Endocrine Society; Asian Breast Cancer Society; Asian Health Coalition; Asian Cancer Foundation ; Asian Pacific Prostate Society; Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery.

Past Conference Report

BreCeCan 2018

Gratitude’s to all of our honorable speakers, conference attendees, and sponsors. BRECECAN 2018 Conference was our best ever!

3^rd World Conference on Breast and Cervical Cancer, hosted by the ME Conferences Group were held during September 24-25, 2018 Abu Dhabi, UAE at Radisson Blu, Golf Plaza, Yas Island, Abu Dhabi, UAE with the theme “Together we can make difference against cancer”. Magnanimous response and active participation were received from the Editorial Board Members of Journal of Integrative Oncology as well as from the Scientists, Doctors, Professors, Oncologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the field of Breast Cancer, who made this event successful.

ME Conferences Group played host to a diverse panel of key members of the BRECECAN 2018 community from research lab, industry, academia, and financial investment practices, discussing the future of oncology, Cancer Genomics, Cancer Epigenetics, and Surgery Choices for Breast Cancer, Breast Cancer Therapy, Prevention, and Management. This event was really aimed for examining where the technology is going in the future and purpose of the event was to provide an opportunity for cross-fertilization and development of ideas, in this field.

Focusing on Breast Cancer Biology, Cervical Cancer Biology, Cancer Genomics, Breast, and Cervical Cancer Screening Male Breast Cancer Breast Reconstruction (Oncoplastic Surgery) Cancer Epigenomics, Women’s Health, Cancer Vaccination the two days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

BRECECAN 2018 Organizing Committee would like to thank the Moderator of the conference Wijdan Alomaim, Fatima College of Health Sciences (FCHS), UAE who contributed a lot for the smooth functioning of this event.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honourable Guests and members of the Keynote forum.

The highlights of the meeting were the eponymous lectures, delivered by:

·         Feroz Agad, SAH Global, USA

·         Mariam Mohd Fatima Matar, UAE Genetic Diseases Association, UAE

·         Yan-Gao Man, International Union for Difficult-to-treat Diseases, USA

·         Femi Ogunremi, National Health Service (NHS), United Kingdom

·         Hazem Khout, Nottingham Breast Institute, United Kingdom

·         Jeethy Ram, Regional Cancer centre, India

·         Mohamad Al-Gailani, Al Hammadi Hospital, Saudi Arabia

·         Samed Rahatli, Baskent University, Turkey

·         Shilpi Narad, HAAD Licensed Specialist Radiation Oncologist, UAE

·         Shruti M Velaskar, Tata Memorial Hospital, India

·         Yoshika Nagata, Shonan Kamakura General Hospital, Japan

·         Maria Aamir, Tawam Hospital, UAE

·         Mouza Mohd Al Ameri, Tawam Hospital, UAE

·         Roaa Atteih, King Abdullah Medical City, Saudi Arabia

·         Mahir Jallo, Gulf Medical University, UAE

·         Sebastian Morales, University of Chile, Chile

·         Lilian Jara, University of Chile, Chile

These talks were of great interest to the general Oncology and were enormously informative.

3^rd World Conference on Breast and Cervical Cancer was a great success with the support of the Journal of Cancer Science & Therapy, Journal of Integrative Oncology, Breast Cancer: Current Research. We are happy to announce our 4^th World Conference on Breast and Cervical Cancer to be held on October 21-22, 2019 in Helsinki, Finland.